A PROSPECTIVE STUDY ON ROLE OF VITAMIN E SUPPLEMENTATION IN TYPE 2 DIABETES MELLITUS

  • Pavithra D Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India
  • Praveen D 2Research Scholar, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India
  • Vijey Aanandhi M Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India.

Abstract

Aim and Objective: The aim of the study was to evaluate the role of Vitamin E supplementation in Type II diabetes mellitus (DM), to determines whether people with Type II DM treated with hypoglycemic agents alone, with or without Vitamin E, to determines the drug interaction in such treatment regimen, and to evaluates the Safety of the regimen.

Methods: Type II DM patients with or without complications were included in this study along with serum glycated hemoglobin (HbA1c) concentration between 7.5% and 9.5%. They are divided into test group (which received hypoglycemic agent along with Vitamin E 4000 IU) and control group. Body mass index (BMI) status, fasting blood sugar (FBS), and post-prandial blood sugar (PPBS) were noted once in a month, HbA1c percentage, total cholesterol level (TC), and serum Vitamin E level were estimated and noted for every 3 months at total 9 months of this study. Patients with other comorbid conditions were prominent in this study.

Results: It is perceptible with the analysis of obtained data that FBS, PPBS, HbA1c percentage, TC level, and BMI status of the patients were declined gradually in test group (patients with Vitamin E supplementation along with their hypoglycemic agents). Thus, antioxidant therapy is highly propitious whereby delaying the onset of complications in patients with DM. This development would be highly helpful for diabetic patients.

Keywords: Antioxidant, Type II diabetes mellitus, Vitamin E, Complications.

References

1. Parks E, Traber MG. The mechanisms of the Vitamin E regulation: The research over the past decade and the focus on the future. Antioxid Redox Signal 2000;2:405-12.
2. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, et al. High-dose Vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with Type 1 diabetes. Diabetes Care 1999;22:1245-51.
3. Narang AP, Grewal RK, Kaur S, Gazetteet R. The role of oxidant stress in diabetic retinopathy. Indian Med Gaz 2002;12:1-2.
4. Weiss WP, Hogan JS, Wyatt DJ. Relative bioavailability of all-rac and RRR Vitamin E based on neutrophil function and total alpha-tocopherol and isomer concentrations in periparturient dairy cows and their calves. J Dairy Sci 2009;92:720-31.
5. Sumien N, Forster MJ, Sohal RS. Supplementation with Vitamin E fails to attenuate oxidative damage in aged mice. Exp Gerontol 2003;38:699-704.
6. . Bieri JG, Teets L, Belavady B, Andres EL. Serum Vitamin E concentrations in a normal adult population in the Washington, D.C Area. Proc Soc Exp Biol Med 1964;117:131-3.
7. . Kuznetsov NS, Abulela AM, NeskoromnyÄ­ VN. The use of antioxidants (alpha-tocopherol acetate) in the treatment of diabetes mellitus. Probl Endokrinol (Mosk) 1993;39:9-11.
8. Jain S, Gaiha M, Bhattacharjee J, Auradha S. The effects of a low dose omega 3 fatty acid substituion in Type 2 diabetes mellitus with special reference to the oxidative stress. A prospective preliminary study. J Assoc Physicians India 2002;50:1028-33. Lee IM.
9. Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in Type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation. Circulation 2000;102:191-6.
10. Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients. Free Radic Biol Med 2000;29:790-2.
11. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, Vitamin E, and Vitamin C on LDL oxidation and products of inflammatory activity in Type 2 diabetes. Diabetes Care 2000;23:733-8.
12. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, et al. High-dose Vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with Type 1 diabetes. Diabetes Care 1999;22:1245-51.
13. Zatalia SR, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones 2013;45:141-7.
14. Brun PJ, Yang KJ, Lee SA, Yuen JJ, Blaner WS. Retinoids: Potent regulators of metabolism. Biofactors 2013;39:151-63.
15. Raghow R. Metabolic balancing acts of Vitamin A in Type-2 diabetes and obesity. World J Diabetes 2012;3:174-7.
16. Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, et al. Plasma levels of lipophilic antioxidants in very old patients with Type 2 diabetes. Diabetes Metab Res Rev 2000;16:15-9.
17. Abahusain MA, Wright J, Dickerson JW, de Vol EB. Retinol, alpha-tocopherol and carotenoids in diabetes. Eur J Clin Nutr 1999;53:630-5.
18. Reunanen A, Knekt P, Aaran RK, Aromaa A. Serum antioxidants and risk of non-insulin dependent diabetes mellitus. Eur J Clin Nutr 1998;52:89-93
19. Gavrilov V, Harman-Boehm I, Amichay D, Tessler G, Shuster T, Friger M, et al. Kidney function and retinol status in Type 2 diabetes mellitus patients. Acta Diabetol 2012;49:137-43.
20. Kotnik P, Fischer-Posovszky P, Wabitsch M. RBP4: A controversial adipokine. Eur J Endocrinol 2011;165:703-11.
21. Pullakhandam R, Palika R, Ghosh S, Reddy GB. Contrasting effects of Type 2 and Type 1 diabetes on plasma RBP4 levels: The significance of transthyretin. IUBMB Life 2012;64:975-82.
Statistics
131 Views | 99 Downloads
Citatons
How to Cite
D, P., P. D, and V. A. M. “A PROSPECTIVE STUDY ON ROLE OF VITAMIN E SUPPLEMENTATION IN TYPE 2 DIABETES MELLITUS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 16, Dec. 2018, pp. 85-89, doi:10.22159/ajpcr.2018.v11s4.31684.
Section
Original Article(s)